Halozyme Therapeutics Inc (HALO)

[maumar]

"Of those "concerns", the one you didn't mention was the skepticism on whether HALO can pull off a deal that adds to the income stream without over-paying for it. I've said so myself many times that the purchase of another company by HALo will not be good for the HALO price per share, and the Goldman guy implied as much."

You are right. I forgot to mention it probably because it is the one that worries me the most. Doing stock buybacks and announcing the intention to make an acquisition at the same time is of course adding to the uncertainty. And yet, if Halo is unable to sign some big deals soon, Helen will be forced to make an acquisition to persuade the investment community that their business model is strong and sustainable. And it is likely to be very expensive. The IPO market is too strong. If you think you have a valuable technology and can go public, why sell to Halo?

I am cautiously optimistic that Phesgo may exceed expectations, we will sign a new deal, and we will soon get more visibility into when SC Efgartigimob will be approved.